Guest Profile

Chris Riedel

Chris Riedel has spent the past 40 years in the healthcare industry, and more recently, as one of the leading healthcare fraud fighters. He founded and served as the CEO of five health care companies: Hunter Heart, Hunter Laboratories, Meris Laboratories (NASDAQ: MERS), MicroScan, and Micro Media systems. In May of 1992, Meris was ranked by Business Week as the 40th best small company in America.

He also has served as a Managing Director for Providence Capital, a boutique New York investment bank, as the Chairman of Chi Laboratory Systems, the pre-eminent hospital and commercial laboratory consulting firm in the U.S., and as a member of the Board of Directors of Boston Heart Lab. Currently, is he is member of Business Executives for National Security (BENS).

For the past decade, Mr. Riedel has concentrated his efforts on fraud fighting against medical labs that are defrauding American taxpayers and the medical industry — the subject of Blood Money. One of his proudest accomplishments came when he received the Taxpayers Against Fraud Whistleblower of the Year Award in 2011 for assisting in the recovery of $286 million from Quest and LabCorp, which he undertook on behalf of California taxpayers. Another accomplishment was developing and receiving FDA new drug approval for a more precise way to identify bacteria causing disease, and which antibiotics and dosage will be most effective in treatment — a product that has saved many lives around the world.

A longtime resident of Silicon Valley, Mr. Riedel makes his home there with his wife, Marcia, and four sons, for whom he served as a soccer and basketball coach for years. He enjoys international travel and is an avid Bay Area sports fan.